What is the recommended pre-operative workup for patients with IgG4 (Immunoglobulin G4) disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pre-operative Workup for Patients with IgG4-Related Disease

For patients with IgG4-related disease, a comprehensive pre-operative workup should include serum IgG4 levels, confirmatory histological diagnosis, assessment of other organ involvement, and evaluation for malignancy before proceeding with surgery. 1

Essential Pre-operative Assessments

Laboratory Evaluations

  • Serum IgG4 levels: Elevated levels support the diagnosis but cannot be relied upon for definitive diagnosis 1
  • Complete IgG panel: Measure total IgG and calculate IgG4/IgG ratio (>40% is supportive) 1
  • Liver function tests: To assess hepatobiliary involvement
  • Inflammatory markers: ESR, CRP to evaluate disease activity

Histological Confirmation

  • Tissue biopsy: Attempts should be made to obtain confirmatory histological diagnosis before surgery 1
    • Look for lymphoplasmacytic infiltration with IgG4-positive plasma cells (>10 per high power field)
    • Evaluate for storiform fibrosis and obliterative phlebitis
    • Perform IgG4 and IgG immunostaining on biopsies with lymphoplasmacytic infiltration 1

Imaging Studies

  • Cross-sectional imaging (CT/MRI): To assess extent of disease and identify other organ involvement
  • MRCP: For evaluation of biliary involvement patterns in IgG4-related sclerosing cholangitis
  • 18F-FDG PET/CT: Helps map sites of inflammation, evaluate disease extent, and guide biopsy decisions 2

Multi-organ Assessment

  • Pancreatic evaluation: Assess for autoimmune pancreatitis, which is present in >80% of IgG4-related sclerosing cholangitis cases 1
  • Salivary and lacrimal glands: Evaluate for involvement as these are common sites
  • Retroperitoneum, kidneys, aorta: Check for additional organ involvement 2

Malignancy Exclusion

  • Biliary brush cytology/biopsy: To rule out cholangiocarcinoma in cases with biliary strictures 1
  • EUS-guided FNA: For pancreatic lesions to exclude malignancy 1
  • Papanicolaou guidelines: Should be used for reporting biliary lesion cytology results 1

Pre-operative Management Considerations

Steroid Trial

  • Consider pre-operative steroid trial (prednisolone 40mg daily for 2-4 weeks) 1
  • Assess objective improvement in radiological abnormalities at 4-8 weeks
  • Lack of response suggests either incorrect diagnosis or fibrotic phase of disease 1

Multidisciplinary Team Discussion

  • MDT review: Patients with complex IgG4-SC and suspected malignancy should be referred to a specialist MDT 1
  • Surgical planning: Complete staging and assessment of operability should be done before deciding on drainage 1

Biliary Drainage Considerations

  • If biliary obstruction is present, consider preoperative biliary drainage in cases of:
    • Cholangitis
    • Jaundice (bilirubin >50 μmol/L)
    • Need for extensive surgery (>50% of liver parenchyma) 1

Pitfalls and Caveats

  • Diagnostic challenges: IgG4-related disease can mimic malignancy, infection, and other immune-mediated disorders 3
  • Serum IgG4 limitations: Up to 30% of patients with IgG4-RD may have normal serum IgG4 levels 1
  • Histopathological interpretation: Requires clinical correlation for accurate diagnosis 4
  • Disease relapse: High relapse rates (60%) after cessation of steroid treatment should be considered in perioperative planning 1
  • Malignancy risk: Careful exclusion of malignancy is essential, as IgG4-RD can be associated with or mimic various cancers 5

By following this structured pre-operative workup, clinicians can better prepare patients with IgG4-related disease for surgery, minimize complications, and optimize outcomes.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

IgG4-related disease: A relatively new concept for clinicians.

European journal of internal medicine, 2016

Research

Proliferative features of IgG4-related disease.

The Lancet. Rheumatology, 2024

Research

Diagnosis and Treatment of IgG4-Related Disease.

Current topics in microbiology and immunology, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.